Products for Research Use Only
RegisterLogin

Oregovomab

CAT: 0804-HY-P99409-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99409-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Oregovomab (Alt-2 monoclonal antibody) is a murine mAb targeting CA125. Oregovomab induces cytotoxic immune response against CA125 expressing tumor cells[1][2].
CAS Number
213327-37-8
Product Name Alternative
Alt-2 monoclonal antibody; MAB-B43.13; Oregovamab
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.66
Solubility
10 mM in DMSO
Smiles
[Oregovomab]
Molecular Weight
(146.72 kDa)
References & Citations
[1]Pietragalla A, et al. Oregovomab: an investigational agent for the treatment of advanced ovarian cancer. Expert Opin Investig Drugs. 2021 Feb;30 (2) :103-110. |[2]Sparholt MH, et al. Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic? APMIS. 2013 Jan;121 (1) :38-44.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
T9901A-046-01Oregovomab
GTR18412425-01Oregovomab Antibody
T9901A-199-01Oregovomab MMAE
HV601036-01Research Grade Oregovomab
C00453-1mg*25Oregovomab (Anti-MUC16)
592081Oregovomab (MUC16, CA125)
GTR18578319-01Oregovomab MMAE Antibody
047997MUC16 (oregovomab) discontinued
KBI1530KRIBIOLISA™ Oregovomab ELISA
E55B0554Oregovomab (Reference antibody)

Popular Products